Ian Mursell
Journal of Paramedic Practice, Vol. 1, Iss. 4, 01 Jan 2009, pp 140 - 144

Cardiovascular disease management has met with success through programmes such as the National Service Framework for Coronary Heart Disease. However, this has led to increased survival and therefore higher prevalence of patients living with impaired cardiac function. Acute cardiogenic pulmonary oedema (ACPO) is one of a number of distinct clinical conditions that result from abnormal cardiac function, primarily referred to as acute heart failure. This article will review current evidence-based pharmacological management of ACPO and make recommendations for future practice in prehospital care. Current drugs used in both prehospital and emergency care will be analysed for safety and efficacy in the management of ACPO.

Return to article listing

To view this article

information Please use the options below to create a subscription. If you have any queries about your account please contact our subscriptions department or telephone free 0800 137201 (UK callers only) or +44 (0)1722 716997 for callers outside the UK.

Existing users sign in Personal subscription Pay per article

Sign in